ADRB3 and obesity disorder: These data suggest that decreased expression of the β3-adrenergic receptor, which is encoded by the Adrb3 gene, and hormone-sensitive lipase (HSL), which in turn causes impaired lipolytic capacity of WAT, leads to metabolic disorders in people with obesity.